Electra Therapeutics, Inc.
ETRA Nasdaq
SEC CIK 2088082
Follow Electra Therapeutics
Weekly email: filings, results
Net income
−$23.9M
−32.3% vs same quarter last year
EPS, diluted
−$3.47
Operating income
−$25.1M
−47.2% vs same quarter last year
Source: SEC XBRL filings · latest filing